Last reviewed · How we verify
1.0% Icotinib hydrochloride cream — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
1.0% Icotinib hydrochloride cream (1.0% Icotinib hydrochloride cream) — Betta Pharmaceuticals Co., Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| 1.0% Icotinib hydrochloride cream TARGET | 1.0% Icotinib hydrochloride cream | Betta Pharmaceuticals Co., Ltd. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- 1.0% Icotinib hydrochloride cream CI watch — RSS
- 1.0% Icotinib hydrochloride cream CI watch — Atom
- 1.0% Icotinib hydrochloride cream CI watch — JSON
- 1.0% Icotinib hydrochloride cream alone — RSS
Cite this brief
Drug Landscape (2026). 1.0% Icotinib hydrochloride cream — Competitive Intelligence Brief. https://druglandscape.com/ci/1-0-icotinib-hydrochloride-cream. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab